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Background: Necrotizing enterocolitis (NEC) is a devastating neonatal gastrointestinal disease that primarily affects
premature infants. It is characterized by bowel inflammation and necrosis. In spite of extensive research, there has
been little progress in decreasing the incidence or mortality of NEC over the past three decades. The exact etiology
of NEC has not been identified. However, it is believed to result from an inappropriate immune response to gut
microbiota. Using 454-pyrosequencing analyses of 16S rRNA genes that were PCR-amplified from stool DNA
specimens, we compared the gut microbiota of infants with NEC to matched controls without NEC. The infants
with NEC were then categorized into three subgroups based on severity: mild, severe, and lethal. We compared
the microbiota among these subgroups and between each severity group and appropriate controls.
Results: Bacterial diversity and the relative abundance of Actinobacteria and Clostridia were significantly lower in
NEC specimens compared to controls. The absence of Clostridia was significantly associated with NEC. Microbial
diversity and Clostridia abundance and prevalence decreased with increasing severity of NEC.
Conclusions: Low bacterial diversity in stool specimens may be indicative of NEC and the severity of NEC. The
low bacterial diversity, and the lack of Clostridia in lethal specimens, could indicate that the presence of a diverse
bacterial population in the gut as well as the presence of taxa such as Clostridia may play a role in attenuating
inflammation leading to NEC.
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Necrotizing enterocolitis (NEC) is a severe neonatal in-
flammatory bowel disease that primarily affects prema-
ture infants [1]. It can lead to bowel necrosis requiring
surgical removal of the affected tissue. Mortality and mor-
bidity are high: up to 50% of cases that require surgery
result in death [2]. Depending on location and extent, sur-
gical bowel removal may result in prolonged dependency
on parenteral nutrition and vitamin administration, slow
growth rate, neurodevelopmental delays, and possibly a
bowel transplant [1,3]. Infants with NEC typically have
longer and more costly hospital stays, and the increased* Correspondence: vmcmur@lsuhsc.edu
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unless otherwise stated.healthcare costs continue through the first 3 years of life
for survivors of surgically treated NEC [4,5]. Unfortu-
nately, there has been no decrease in either the incidence
or the mortality rate of NEC over the last three decades,
indicating a need for better treatment options and im-
proved preventative measures [6].
The exact etiology of NEC is not known and presumed
to be multifactorial. While evidence suggests that the
presence of bacteria in the gut is necessary for patho-
genesis [7,8], a combination of inappropriate immune
responses, genetic predisposition, microvascular tone,
and bacteria in the gut all may contribute to the disease
[9]. There is no consensus regarding the diversity or
composition of microbiota associated with this disease.
For example, two studies show that diversity is signifi-
cantly decreased in NEC, both at diagnosis [10] and inral. This is an Open Access article distributed under the terms of the Creative
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difference in diversity between NEC and controls in the
week prior to NEC or within 72 h of diagnosis [12-14].
Concerning the relationship between the composition
of microbial communities and NEC, some investigations
show that Proteobacteria are increased prior to and during
the onset of NEC [11,12,14], and others demonstrate that
Enterobacteriaceae, a family within the phylum Proteobac-
teria, are decreased in infants with NEC within the week
prior to diagnosis [15]. A predominance of both Firmicutes
and Proteobacteria has been hypothesized to be related
to the time of onset of NEC with a predominance of
Firmicutes during day of life (DOL) 4 to 7 having an
earlier onset than Proteobacteria predominance during
DOL 10 to 16 [11]. Finally, some studies show no differ-
ence in bacterial composition between NEC and con-
trols [13,16]. Thus, no individual species or bacterial
community has been found to be consistently associated
with NEC.
Although it is well recognized that not all cases of
NEC are equally severe, the level of severity is not typic-
ally a variable considered in analyses of the microbiota
of patients with NEC, even though there are clinical
differences in severity and resulting treatment [17]. We
postulated that the microbiota of infants with the most
severe form of NEC, that is, those that succumbed to
the disease, would be significantly different from that of
controls. Conversely, the microbiota of infants with less se-
vere forms of NEC might more closely resemble that of
controls. We stratified NEC cases into three categories,
mild, severe, and lethal, based on severity and outcome,
and compared the microbiota across each category as well
as matched controls for each group. We also compared the
microbiota of all NEC cases to those of matched controls.
Results
Patient cohort
Based on the 12 clinical parameters evaluated, our
cohort of 21 NEC infants was well-matched with the 74
controls (Additional file 1: Table S1). Considering the
total cohort, NEC subjects tended to be slightly less
mature than their control counterparts and tended to
have more frequent use of H2 blockers. There were oc-
casional trends within the subgroups, as well as a signifi-
cant difference in caffeine administration between NEC
and control subjects in the mild NEC group. However,
this finding was not duplicated in the other subgroups
nor in the total cohort and may simply reflect the small
numbers. It should be noted that we excluded antibiotics
given on the day of diagnosis from the definition of
recent antibiotic administration. Many of the specimens
collected from premature infants with NEC were taken
on the same day as diagnosis. Thus, collection of the
stool coincided with the start of intravenous antibiotics.However, it is unlikely that a single dose of antibiotics
given within a few hours of collection would significantly
change the bacterial genetic material in stool.
Microbiota analyses
Several notable differences were observed between the
microbiota of total NEC specimens and controls and be-
tween the microbiota in the three categories of NEC.
The results of all comparisons are summarized in tabu-
lar form (Additional file 1: Table S2). We found that the
abundance of bacteria within the class Actinobacteria
(Additional file 1: Table S2) and the class Clostridia
(Figure 1C) was significantly lower in total NEC speci-
mens compared to controls, P = 0.009 and P = 0.004,
respectively. We found no difference in abundance of
Bacilli (Figure 1A) or Gammaproteobacteria (Figure 1B).
The abundances of two bacterial genera, Veillonella and
Streptococcus, were significantly lower in total NEC speci-
mens compared to controls, P = 0.007 and P = 0.002, re-
spectively (Additional file 1: Table S2). Principle coordinate
analysis of unweighted UniFrac distances showed no dis-
tinct separation between microbial communities in total
NEC specimens and control specimens indicated by R
values close to zero (Figure 2). Although the unweighted
UniFrac P value is statistically significant (P = 0.001;
R = 0.2309), the low R value suggests that the communities
are essentially not separable, that is, NEC specimens are as
different from each other as they are from controls. We
found that both Chao1 richness (Figure 3A) and Shannon’s
diversity (Figure 3B) were significantly lower in total
NEC specimens compared to controls, P < 0.0001 and
P = 0.0002, respectively. We performed an ANOVA using
the operational taxonomic unit (OTU) abundance table to
test whether there were any OTUs that were significantly
different between NEC and controls using OTUs present
in at least 25% of specimens (102 total OTUs). None were
found to be significantly different after false discovery rate
(FDR) correction (Additional file 1: Table S3).
We focused our analyses of the microbiota in mild, se-
vere, and lethal categories of NEC specimens on diver-
sity and class-level assessments of the microbiota. Lethal
NEC specimens showed a complete absence of bacteria
in the class Clostridia, and this class was significantly
less abundant (P = 0.007) in these specimens compared
to controls (Additional file 1: Table S2). The class Acti-
nobacteria was significantly reduced in severe NEC spec-
imens compared to controls, P = 0.044 (Additional file 1:
Table S2). Chao1 richness, an indirect measure of rich-
ness, was significantly lower in all three categories of
NEC specimens, lethal (P = 0.005), severe (P = 0.002), and
mild (P = 0.003), compared to their respective controls
(Additional file 1: Figure S1 A, C, E). Shannon’s diversity,
an indirect measure of evenness, was also significantly
lower in each category of NEC specimens compared to
Figure 1 Relative abundance of taxonomic differences between NEC stool specimens and controls. Relative abundance of the most
abundant taxa at class level (A-C) for NEC specimens (n = 21) compared to controls (n = 74) as well as the abundance at the different severities
of NEC (D-F). Clostridia was significantly reduced in NEC patients (C), and as the severity of NEC decreased, the abundance of Clostridia
increased. Lethal NEC, n = 6; severe NEC, n = 7; and mild NEC, n = 8. The solid line represents the mean, and the standard deviation is represented
by dashed lines when between 0 and 100. (A-C) Significance was determined using a Mann-Whitney U test. For comparison of the NEC levels,
Kruskal-Wallis test was used from (D-F). *P value < 0.05, **P value < 0.01. NEC, necrotizing enterocolitis.
McMurtry et al. Microbiome  (2015) 3:11 Page 3 of 8their respective controls, lethal P = 0.04, severe P = 0.03,
and mild P = 0.01 (Additional file 1: Figure S1 B, D, F).
To investigate whether the prevalence, relative abun-
dance, or diversity of specific bacterial taxa is associated
with the degree of NEC severity, we compared the micro-
biota across the three categories of NEC. We found that
as the severity of NEC increased, the prevalence and
relative abundance of Clostridia decreased. In contrast,
bacteria in the classes Bacilli and Gammaproteobacteria
showed no similar trend (Figure 1D, E). The average abun-
dance of Clostridia was 12% in mild NEC, 3% in severe
NEC, and 0% in lethal NEC (Figure 1F), and Clostridia
abundance in lethal NEC specimens was significantly
lower than that in mild NEC specimens (P = 0.025). The
average prevalence of Clostridia likewise decreased, 75%
(6/8) in mild NEC, 43% (3/7) in severe NEC, and 0% (0/6)
in lethal NEC. In light of this information, we used Fisher’s
exact test to determine whether there was an associationbetween the absence of Clostridia and the presence of
NEC. Of the 74 controls, only 14 (19%) lacked Clostridia,
while 12 of 21 (57%) of NEC specimens lacked this taxon
(P = 0.002). The average Chao1 diversity and Shannon’s di-
versity also increased as the severity of NEC decreased
(Figure 3C, D).Discussion
Studies of the microbiota of infants with NEC have re-
vealed no consistent pattern of bacterial taxa associated
with this disease. Since all NEC cases differ clinically, we
stratified our NEC subjects into three categories based
on the level of severity of the disease, postulating that
the most extreme cases, those in which an infant suc-
cumbs to the disease, would provide the best opportunity
to identify aberrations of microbiota statistically associated
with NEC.
Figure 2 Principal coordinate analysis (PCoA) of NEC compared to controls. Unweighted UniFrac uses phylogenetic information to compare
specimens that can be visualized with PCoA plots. The gray circles represent the control specimens (n = 74), blue circles represent mild NEC
specimens (n = 8), red circles represent severe NEC specimens (n = 7), and green circles represent lethal NEC specimens (n = 6). ANOSIM was used
to evaluate the UniFrac distances of all NEC vs controls. Although the P value is statistically significant (P = 0.001), the R value (0.2309) suggests
that the communities are essentially not separable. PC, principal coordinate.
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case-control study of fecal microbiota in premature in-
fants with and without NEC that suggest that variation in
disease severity is correlated with a spectrum of bacterial
dysbiosis. Bacterial diversity, as measured by both Chao1
richness and Shannon’s index, was clearly decreased in the
NEC specimens compared to controls in the total NEC
group (Figure 3), and this trend toward lower diversity
was also observed across NEC subgroup; as diversity
decreased, the level of NEC severity increased (Additional
file 1: Figure S1). The level of microbial diversity in NEC
is controversial. Some studies have found no difference in
diversity between NEC and control samples a week prior
or >72 h prior to diagnosis [12-14]. Our data supports the
results of two investigations that found low bacterial di-
versity associated with NEC [10,11]. Furthermore, in our
study, microbial diversity tended to decrease with increas-
ing disease severity (Figure 3), supporting the concept of a
spectrum of bacterial dysbiosis. In adults, low bacterial
diversity in the gut has been associated with inflamma-
tory bowel disease (Crohn’s disease) and with greater
abdominal discomfort levels in patients with food intol-
erances [18,19]. In infants, low bacterial diversity during
the first month of life preceded the development of
asthma at school age [20]. These observations suggest
that low intestinal bacterial diversity may negatively
affect the immune system.Regarding bacterial composition of the intestinal micro-
biota, Bacilli and Gammaproteobacteria accounted for
most of the relative abundance in both control and NEC
samples (Additional file 1: Table S2). Although the relative
abundances of both classes varied widely across the con-
trol samples, they appeared to be clustered at abundance
extremes in the NEC samples, again reflecting decreased
diversity (Figure 1). This clustering phenomenon has been
reported by other investigators [11] and belies the hypoth-
esis that NEC is predominantly a Gram-negative disease.
A significant factor complicating any study of the
microbiota associated with NEC is the almost universal ad-
ministration of antibiotics to premature infants. Increased
Enterobacter and decreased diversity have been found in
premature infants who have received antibiotics early in
life [21]. However, in our study, there was no difference be-
tween NEC and control groups’ past use of antibiotics
(Additional file 1: Table S1), and Enterobacter abundances
did not differ between NEC and controls (data not shown).
It is unlikely that the first stool after administration of the
first dose of antibiotics would show the changes present in
following stool specimens since the composition of DNA
from the microbiota would be the same as before the
administration of antibiotics. At this time, it is unclear
what factors predispose a microbiota to shift in one direc-
tion or another, but further research in this area may pro-
vide clues for preventive and/or therapeutic measures.
Figure 3 Microbial alpha diversity. Chao1 richness estimation (A) and Shannon’s diversity index (B) were used to measure alpha diversity. NEC
specimens (n = 21) were significantly lower than controls (n = 74) for both measures of diversity. These measures were also used to compare
the different severities of NEC (C, D). Lethal NEC, n = 6; severe NEC, n = 7; and mild NEC, n = 8. Solid lines represent the mean with standard
deviation represented by dashed lines. (A, B) were evaluated with a Mann-Whitney U test, and (C, D) were evaluated with a Kruskal-Wallis test.
***P value <0.001, ****P value < 0.0001. NEC, necrotizing enterocolitis.
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mens taken immediately prior to or shortly after the diag-
nosis of NEC. NEC is certainly a multifactorial disease, and
other physiological processes that take place during NEC
could affect the microbiota.
Although we found no bacterial taxon or community
that was consistently associated with NEC, there ap-
peared to be at least one notable absence. All six stool
specimens from the infants with lethal NEC lacked rep-
resentatives of the class Clostridia. In contrast, Clostridia
contributed a mean relative abundance of almost 15%
(range: 0% to 85%) in controls (Figure 1C). The percent
abundance of Clostridia decreased as the severity of NEC
increased (Figure 1F). Considering the entire infant co-
hort, the absence of Clostridia was strongly associated
with NEC (P = 0.002, Fisher’s exact test). This is in agree-
ment with the findings of Smith et al. who found Clostrid-
ium via in situ hybridization (FISH) in only 4 out of 24surgical specimens from patients with NEC [22] corre-
sponding to our severe NEC group.
Certain Clostridia, namely members of clusters XIVa,
IV, and XVIII, have been shown to decrease inflammation
in the gut during allergic diarrhea in mice and increase
differentiation of FOXP3+ regulatory T cells (Tregs) [23].
Tregs play a vital role in gut immune homeostasis by
inhibiting innate and adaptive immune responses [24-26].
Decreased Treg number and function predisposes the gut
to increased inflammation. Weitkamp et al. reported that
the proportion of Tregs, as well as ratios of Treg/CD4 T
cells and Treg/CD8 T cells, were lower in lamina propria
mononuclear cells isolated from surgical specimens of
ileum from NEC patients compared with controls [27]. In
a rat pup model, Tregs were reduced eightfold after induc-
tion of experimental NEC [28]. Administration of exogen-
ous Tregs prior to induction of NEC resulted in reduced
incidence of NEC, improved survival, and decreased tissue
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dendritic cells by suppressing upregulation of CD80 and
to modulate trafficking of effector cells in the mesenteric
lymph nodes [28]. Decreased abundance of Clostridia has
been linked to other examples of human inflammatory
bowel disease, for example, Crohn’s disease [18,29,30], and
to increased abdominal discomfort in cases of food aller-
gies [19]. Whether the relative abundance of Clostridia in
stool specimens may serve as a useful marker of the tra-
jectory of gut microbial development toward health or dis-
ease warrants further investigation.
Conclusions
In summary, a number of studies have focused on describ-
ing the composition of the gut microbiota associated with
NEC [10,12-16]. However, there is still no consensus re-
garding the composition of gut bacteria associated with
this condition. Rather than identifying the presence of
certain bacteria in association with NEC, our data suggest
that the absence of certain bacterial classes, such as
Clostridia, and a reduction in bacterial diversity of the gut
may represent risk factors for NEC. We postulate that the
presence of these taxa and their immunoregulatory func-
tions are necessary to prevent an overly robust inflamma-
tory response. In the absence of these ‘protective’ taxa, the
presence of a variety of other bacterial taxa can lead to ex-
aggerated inflammation and NEC.
Methods
Ethical statement
This study is part of an ongoing, multicenter investiga-
tion of the factors affecting the postnatal development of
fecal microbiota in premature infants. It was approved
by the institutional review boards of Louisiana State
University Health Sciences Center, Touro Infirmary, East
Jefferson General Hospital, and Children’s Hospital of
New Orleans (IRB #6728).
Study population
Patients were continually enrolled in a study of the gut
microbiota from 2007 to 2011. Written consent was ob-
tained upon the patient’s admittance to the neonatal inten-
sive care unit (NICU), and the patient’s stool was collected
at each bowel moment until the patient was discharged
from NICU. We choose 95 premature infants ≤1,500 g
and/or ≤34 weeks of gestation that were enrolled in the
study, including 21 infants with NEC and 74 age-, gesta-
tional age-, and birth weight-matched infants without
NEC (controls). Other clinical parameters of the infants
were noted, but not considered for matching (Additional
file 1: Table S1). NEC was defined clinically by the pres-
ence of abdominal distension, feeding intolerance, bloody
stools, radiographically by demonstration of pneumatosis
intestinalis on abdominal X-ray (Bell stage II or greater)[17], and/or by pathology evidence of mucosal inflamma-
tion/obliteration and ischemia/hemorrhagic necrosis. Two
of the 21 NEC patients did not exhibit pneumatosis intes-
tinalis on abdominal X-ray. In each case, the diagnosis
was suspected by clinical presentation and confirmed by
pathological examination of surgical or autopsy specimens
[31]. Surgically treated and lethal NEC cases were con-
firmed by pathology examination of surgical or autopsy
specimens. For the purposes of our study, the premature
infants with NEC were subdivided into three categories:
mild, severe, and lethal. The mild NEC group (n = 8) in-
cluded patients that were successfully managed medic-
ally by 10 to 14 days of bowel rest, decompression, and
broad-spectrum intravenous antibiotics. The severe NEC
group (n = 7) included patients that required prolonged
medical management (>14 days) or surgical intervention
due to intestinal perforation. The lethal NEC group (n = 6)
included fatal cases, regardless of treatment. Stools from
NEC infants were matched with three to five stools from
control infants matched for gestational age (GA), birth
weight (BW), and DOL when the sample was taken.
Stool sample collection and analytic methods
One stool sample was included from each study subject.
Stool specimens from patients with NEC were collected
from 1 to 5 days prior to onset of symptoms or on the
day of diagnosis. Control specimens (n = 74) were selected
on the basis of age, gestational age, and birth weight from
the pool of samples collected serially from infants enrolled
in the multicenter study during their stay in the NICU. All
samples were placed in a nucleic acid preservative at the
time of collection and stored frozen until extraction of
DNA using a Qiagen QIAamp mini kit (Qiagen, Venlo,
The Netherlands), as previously described [32]. The micro-
biota in stool specimens was characterized using 454-
pyrosequencing analysis of PCR-amplified segments of the
V1 to V3 region of the 16S rRNA gene using primers 27 F:
GAGTTTGATCNTGGCTCAG and 519R: GWNTTAC
NGCGGCKGCTG. Our forward primer is very similar to
the 27 F bacterial primer that has been used in other stud-
ies of NEC [12,14]. The C at position 11 in the 27 F primer
has been replaced by a mixture of A, T, G, and C; this
allowed us to expand the number of bacterial taxa targeted
by the primer. This includes an increase in the phyla
Actinobacteria (23450 to 34037), Bacteroidetes (40349
to 55791), and Proteobacteria (113839 to 176807). The
primer set used has a known bias against Gardnerella
species, targeting 17/101 using the Ribosomal Database
Project (RDP) probe match. The 519 reverse primer was
used in order to target as many variable regions (V1 to
V3) as possible using the 454-pyrosequencing platform.
Sequences were analyzed using the QIIME pipeline [33].
A total of 657,504 sequences were included in the study.
The average number of sequences per specimen was 6,921
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The average sequence length was 355 bases. Sequences
with >6 ambiguous bases, homopolymers >6 bases in
length, any mismatches in the primer, or a mean quality
score <25 on a scale of 0 to 40 were eliminated. Chimeric
sequences were identified and removed using UCHIME
[34]. Sequences were aligned using PyNast [35] and the
Greengenes core reference alignment [36] and clustered
into OTUs at 97% similarity using USEARCH [37] with a
minimum of two sequences per OTU. A total of 1,277
OTUs were formed. A phylogenetic tree was created using
FastTree [38]. Taxonomic identification of OTUs was
performed using the RDP classifier using a confidence of
0.8 [39]. Bacterial diversity, as well as the prevalence and
abundance of each phylum, class, and genus in each stool
specimens, was calculated. We compared the prevalence
and relative abundance of microbiota in stool specimens,
at the phylum, class, and genus levels, as well as the diver-
sity of OTUs, in NEC and control infants, and in NEC in-
fants at each of three levels of severity at the phylum and
class level. Diversity was measured by Chao1 and Shan-
non’s indexes using the average of 50 iterations in which
800 sequences were randomly subsampled from each
specimen. Lethal NEC compared to matched controls,
severe NEC compared to matched controls, and mild
NEC compared to matched controls used data from the
complete analysis instead of separate analysis to remove
possible complicating factors that can result from clus-
tering methods and randomization of subsampling in
diversity estimations.
Statistical methods
Continuous clinical variables were analyzed using the
unpaired t-test. Discrete variables were analyzed using
Fisher’s exact test with Yate’s continuity correction or, in
the case of feeding type, Pearson’s chi-square test for inde-
pendence (Instat 3 for Windows, GraphPad Software, La
Jolla, California, USA, www.graphpad.com). The Kruskal-
Wallis rank sum test was used to evaluate differences in
the relative percent abundance of taxa or diversity in three
or more categories of specimens followed by Dunn’s test
of multiple comparisons (R version 3.1.1, stats and
Dunn’s test). A Mann-Whitney U test was used to assess
statistical differences in relative percent abundance of
taxa in two categories of specimens (R version 3.1.1,
stats). Weighted and unweighted UniFrac measurements
were used to measure distances between microbial com-
munities in two categories of specimens, and principle
coordinate analyses were used to assess the separation
between two categories of specimens [40]. Analysis of simi-
larity (ANOSIM) in QIIME was used to evaluate the sig-
nificance of unweighted and weighted UniFrac distances
between categories [33]. Analysis of variance (ANOVA)
with FDR correction was used within QIIME to determinewhether OTU relative abundance is different between
NEC and controls [33]. The acceptable type 1 error was
set at α < 0.050 (two-tailed test).
Availability of supporting data
The data set supporting the results of this article is
included within the additional files as supplemental in-
formation. The sequences, quality scores, and specimen
descriptions are publicly available at http://dx.doi.org/
10.6084/m9.figshare.1327660.
Additional file
Additional file 1: Data set supporting the results of the article.
Table S1. Clinical description of subject groups at time of specimen
collection. Table S2. Differences in relative abundance. Table S3. ANOVA
of OTU abundances. Figure S1. Diversity of lethal, severe, and mild NEC
specimens compared to controls.
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